Results 11 to 20 of about 74,737 (254)
Pyridostigmine Treatment for Pediatric Axonal Guillain-Barré Syndrome. [PDF]
ABSTRACT Introduction/Aims Direct involvement of the neuromuscular junction (NMJ) in the inflammatory process of Guillain–Barré syndrome (GBS) has been described. Despite this, the NMJ very rarely serves as a target for direct medical intervention in GBS.
Zohar-Dayan E +3 more
europepmc +2 more sources
The Differential Diagnosis of Coma in the ICU: Hyperacute Postoperative Guillain-Barré Syndrome-A Case Report. [PDF]
ABSTRACT Guillain‐Barré syndrome (GBS) is a rare, immune‐mediated neurological disorder that can be challenging to diagnose in postoperative patients due to atypical manifestations and overlapping conditions. This case report highlights the diagnostic and therapeutic challenges of GBS following vascular surgery. We present the case of a 56‐year‐old man
Tiganas M +3 more
europepmc +2 more sources
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
Background Reports of Guillain-Barre Syndrome (GBS) have emerged during the Coronavirus Disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS.
S. Keddie +41 more
semanticscholar +1 more source
Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
Guillain–Barré syndrome (GBS) is a rare immune-mediated acute polyradiculo-neuropathy that typically develops after a previous gastrointestinal or respiratory infection. This narrative overview aims to summarise and discuss current knowledge and previous
J. Finsterer
semanticscholar +1 more source
Introduction: Guillain-Barré syndrome is an immune-mediated inflammatory polyneuritis characterised by rapidly progressive flaccid paralysis. Guillain-Barré syndrome may present with posterior reversible encephalopathy syndrome or reversible cerebral ...
Haruka Kobayashi +3 more
doaj +1 more source
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
Key Points Question Are COVID-19 vaccines associated with Guillain-Barré syndrome (GBS)? Findings In this cohort study of surveillance data from the Vaccine Safety Datalink that included 15.1 million doses of COVID-19 vaccines, the unadjusted incidence ...
K. Hanson +13 more
semanticscholar +1 more source
Background and objectives: Guillain–Barré Syndrome is one of the most common causes of acute polyneuropathy in adults. Recently, the occurrence of Guillain–Barré Syndrome after major and minor surgical operations has been increasingly debated.
Mensure Yılmaz Çakırgöz +8 more
doaj +3 more sources
Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré Syndrome. [PDF]
ABSTRACT Background and Aims Understanding of population‐level outcomes for patients with Guillain–Barré syndrome (GBS) remains limited. We identified which GBS patients are most likely to experience worse outcomes using the largest and most current GBS cohort in the United States.
Wright B +5 more
europepmc +2 more sources
Guillain-Barré syndrome: a century of progress [PDF]
In 1916, Guillain, Barré and Strohl reported on two cases of acute flaccid paralysis with high cerebrospinal fluid protein levels and normal cell counts — novel findings that identified the disease we now know as Guillain–Barré syndrome (GBS).
A Campbell +91 more
core +1 more source
Objective: Guillain-barré syndrome is the most common and most severe acute paralytic neuropathy. This study is also aimed at to know that if there is any association of parameters of complete blood count and whether these can be used as a prognostic ...
Nauman Aziz +5 more
doaj +2 more sources

